A gene-augmentation framework for selected early-stage autosomal recessive retinitis pigmentosa genotypes
This study establishes a preclinical framework for developing gene-augmentation therapies for early-stage autosomal recessive retinitis pigmentosa by identifying 19 tractable genotypes, validating cell-specific promoters in rhesus monkeys, and demonstrating that AAV8-mediated PDE6B delivery preserves retinal structure and function in mouse models while showing dose-dependent safety profiles.